AnaptysBio, Inc. (ANAB)
63.15
+0.96
(+1.54%)
USD |
NASDAQ |
May 15, 16:00
63.22
+0.07
(+0.11%)
After-Hours: 20:00
AnaptysBio EPS Diluted (Quarterly) : -1.843 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.8168 |
| TG Therapeutics, Inc. | 0.1236 |
| ADMA Biologics, Inc. | 0.1889 |
| Mirum Pharmaceuticals, Inc. | -13.43 |
| Rocket Pharmaceuticals, Inc. | -0.4244 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -52.88M |
| Revenue (Quarterly) | 25.56M |
| Total Expenses (Quarterly) | 78.44M |
| Enterprise Value | 1.829B |
| Gross Profit Margin (Quarterly) | 97.61% |
| Profit Margin (Quarterly) | -206.9% |
| Earnings Yield | -1.71% |
| Operating Earnings Yield | 2.19% |
| Normalized Earnings Yield | -1.711 |